Baxter is firmly committed to support patients and their healthcare providers throughout the entire continuum of care - from acute kidney injury to end-stage chronic kidney disease.
Introducing the next evolution in hemodialysis that brings us a step closer to the natural kidney through superior removal of an expanded range of conventional/large middle molecules (up to 45,000 Da),